NIH-funded research R01 grant

Oxidative stress in age-related osteoarthritis

Official title: Oxidative Stress and the Development of Osteoarthritis

Funded at Univ of North Carolina Chapel Hill · NIH-11299495 · Data updated 2026-11-12

Looking at whether too much damaging oxygen activity in joint cells causes cartilage breakdown in older adults with osteoarthritis.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startSeptember 30, 2012
Project endFebruary 29, 2028
Funding year2026
Award (this year)$409,075
NIH project number5R01AG044034-14
Project IDNIH-11299495 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates would be older adults with age-related osteoarthritis of the knee or hip or individuals willing to donate joint tissue or cells for research.

Less likely to help

People with recent traumatic joint injuries or those seeking immediate symptom relief from current treatments are unlikely to receive direct benefit from this basic-science-focused project.

What this research studies

This research looks at how an imbalance between reactive oxygen species (ROS) and antioxidant proteins called peroxiredoxins affects cartilage cells and promotes age-related osteoarthritis. The team uses human cartilage cells and genetically modified mice to study changes in cell signaling pathways such as JNK, AKT, and NFκB that lead to cell aging and inflammation. They also test whether boosting peroxiredoxin activity in chondrocytes can protect joints from age-related damage. Lab experiments are paired with analysis of human tissue samples to connect the findings to people with osteoarthritis.

Why it matters

Potential benefit: If successful, the work could identify new ways to protect cartilage or slow age-related osteoarthritis by targeting oxidative damage and cellular aging.

How similar studies have gone: Prior lab and animal studies have linked oxidative stress and cellular senescence to osteoarthritis and some antioxidant approaches reduced damage in animals, but translation to proven clinical therapies remains limited.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Loeser, Richard F — Univ of North Carolina Chapel Hill
  • Study coordinator: Loeser, Richard F

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.